Evicenter
P&T meetings

Zanzalintinib (XL092)

Metastatic colorectal cancer

Manufacturer
Exelixis
Regulatory submission
NDA submitted December 2025
Launch
Not announced
Last updated
65 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology

Incidence of Metastatic colorectal cancer

3 evidence topics · 2 sources

U.S. incidence, all colorectal cancer stages

“The rate of new cases of colorectal cancer was 37.6 per 100,000 men and women per year.” (opens the source at this quote in a new tab)

Estimated U.S. new cases in 2026, all colorectal cancer stages

“There will be an estimated 158,850 new cases of CRC in the United States in 2026” (opens the source at this quote in a new tab)

Distant-stage disease at diagnosis
SEER measureDirect quotation
Percentage diagnosed at distant stage“23%”